EMvision Medical Devices Ltd.ASX: EMV

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by EMvision Medical Devices Ltd. via ASX

Filed with ASX · · 12 pages · English

Summary by 6ix AI

Emvision maintains a strong financial position with cash reserves increasing from the previous quarter, supporting ongoing clinical and regulatory milestones. The company has signed a memorandum of understanding with the Australian Stroke Alliance to pursue funding for pre-hospital stroke diagnosis research.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

26/10/2026 EMVision Medical Devices Ltd ACN 620 388 230 Suite 4.01, 65 Epping Rd Sydney NSW 2113 02 8667 5337 contact@emvision.com.au APPENDIX 4C – 30 SEPTEMBER 2026 QUARTERLY ACTIVITIES & CASHFLOW REPORT Highlights • By early October, the Pivotal (Validation) trial surpassed 230 patients...

EMvision Medical Devices Ltd. on 6ix

Earlier from EMvision Medical Devices

Later from EMvision Medical Devices

All EMvision Medical Devices news releases